Interviews by Dr. MittendorfDr. Mittendorf discusses key takeaways from the Impassion-131 clinical trial investigating first-line atezolizumab in combination with chemotherapy in metastatic triple-negative breast cancer (TNBC) presented at the 2020 ESMO Virtual Congress.
|
Tweets by @EMittendorfMD
|
Enjoy the highlights from the 2019 Susan F. Smith Center Executive Council Beyond Boston Luncheon, which features Dr. Mittendorf discussing the success of the Women's Breast Program.
Dr. Mittendorf Discusses Immunotherapy Efforts in Breast Cancer
Dr. Mittendorf Discusses Rationale for Updating AJCC Staging System
|